Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VivaGel for Bacterial Vaginosis
NCT01577537Phase 3Completed
- Sponsor
- Starpharma
- Start
- Apr 2012
- Primary completion
- Oct 2012
- Modality
- Peptides, Polymer-based Nanoparticles
01
Overview
Phase 3, randomised, double-blind trial in bacterial vaginosis (BV) comparing VivaGel with HEC Placebo (2 arms). Primary endpoint: Number of Women With Clinical Cure at the End of Treatment Visit (EOT). Started Apr 2012; status: completed.
02
Drugs
astodrimer
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT01577537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01577537.